Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Pituitary Neoplasms 1Osteoporosis 1Fractures, Bone 1Breast Neoplasms 1

Interventions

Dexmedetomidine 3Cabergoline 3pegvisomant 1pasireotide 1lanreotide 1Trimethoprim 1Sulfamethoxazole 1Sodium Chloride 1Sevoflurane 1Saline Solution 1Propofol 1Prednisone 1Octreotide 1Ibuprofen 1Hydrocortisone 1Hormone Replacement Therapy 1Cefdinir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Pituitary Neoplasms × Hormone Replacement Therapy × Clear all
NCT06679816 2025-01-14

Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors

Beijing Tiantan Hospital

Phase 4 Recruiting
882 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡